Global Immuno Oncology Assays Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Immuno Oncology Assays Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoint receptors, bi-specific antibodies, small molecules, or cellular therapies such as chimeric antigen receptor T-cells (CAR-T).
Immuno Oncology Assays report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immuno Oncology Assays market is projected to reach US$ 9297.8 million in 2033, increasing from US$ 4439.4 million in 2022, with the CAGR of 10.9% during the period of 2023 to 2033. Demand from Research and Clinical Diagnostics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immuno Oncology Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Immuno Oncology Assays key companies include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies are top 3 players and held % share in total in 2022.
Immuno Oncology Assays can be divided into Immunoassay, Flow Cytometry, PCR and Next Generation Sequencing, etc. Immunoassay is the mainstream product in the market, accounting for % share globally in 2022.
Immuno Oncology Assays is widely used in various fields, such as Research and Clinical Diagnostics, etc. Research provides greatest supports to the Immuno Oncology Assays industry development. In 2022, global % share of Immuno Oncology Assays went into Research filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immuno Oncology Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
Segment by Type
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Research
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immuno Oncology Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immuno Oncology Assays introduction, etc. Immuno Oncology Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Immuno Oncology Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Immuno Oncology Assays report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Immuno Oncology Assays market is projected to reach US$ 9297.8 million in 2033, increasing from US$ 4439.4 million in 2022, with the CAGR of 10.9% during the period of 2023 to 2033. Demand from Research and Clinical Diagnostics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Immuno Oncology Assays industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Immuno Oncology Assays key companies include Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies and Illumina, etc. Thermo Fischer Scientific, Roche Diagnostics, Agilent Technologies are top 3 players and held % share in total in 2022.
Immuno Oncology Assays can be divided into Immunoassay, Flow Cytometry, PCR and Next Generation Sequencing, etc. Immunoassay is the mainstream product in the market, accounting for % share globally in 2022.
Immuno Oncology Assays is widely used in various fields, such as Research and Clinical Diagnostics, etc. Research provides greatest supports to the Immuno Oncology Assays industry development. In 2022, global % share of Immuno Oncology Assays went into Research filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Immuno Oncology Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Thermo Fischer Scientific
Roche Diagnostics
Agilent Technologies
Illumina
Segment by Type
Immunoassay
Flow Cytometry
PCR
Next Generation Sequencing
Segment by Application
Research
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Immuno Oncology Assays market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Immuno Oncology Assays introduction, etc. Immuno Oncology Assays Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Immuno Oncology Assays market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices